Trials / Conditions / Recurrent Thyroid Gland Medullary Carcinoma
Recurrent Thyroid Gland Medullary Carcinoma
4 registered clinical trials studyying Recurrent Thyroid Gland Medullary Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced NCT04514484 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | GFRα4 CAR T Cells in MTC Patients NCT04877613 | University of Pennsylvania | Phase 1 |
| Active Not Recruiting | Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wi NCT02867592 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Canc NCT00390325 | National Cancer Institute (NCI) | Phase 2 |